PAVM
PAVmed Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.28
+3.73%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 112.0K | 71.0K | 3.0M | 2.5M | 377.0K |
| Cost of Revenue | 397.0K | 323.0K | 6.0M | 6.4M | 3.6M |
| Gross Profit | (285.0K) | (252.0K) | (3.0M) | (4.0M) | (3.2M) |
| Operating Expenses | |||||
| R&D Expense | 6.4M | 4.5B | 5.9M | 14.3M | 25.3M |
| SG&A Expense | 17.2B | 17.2B | 36.2M | 48.5M | 60.7M |
| General & Admin Expense | 16.3B | 16.3B | 24.5M | 30.9M | 41.4M |
| Selling & Marketing Expense | 917.0M | 917.0M | 11.6M | 17.6M | 19.3M |
| Other Expenses | (17.1B) | (21.6B) | (639.0K) | 2.0M | 1.8M |
| Total Operating Expenses | 26.4M | 21.6M | 41.4M | 64.8M | 87.8M |
| Cost and Expenses | 26.8M | 21.9M | 47.5M | 71.2M | 91.5M |
| Operating Income (EBIT) | (26.7M) | (21.8M) | (44.5M) | (68.8M) | (91.1M) |
| Non-Operating | |||||
| Interest Income | 44.0K | 29.0K | 254.0K | 505.0K | 169.0K |
| Interest Expense | 18.0K | 21.0K | 45.0K | 589.0K | 1.3M |
| Net Interest Income | 26.0K | 8.0K | 209.0K | (84.0K) | (1.1M) |
| Other Non-Op Income/Expense | 10.3M | 19.3M | 72.9M | (10.5M) | (12.2M) |
| Non-Operating Income (excl Interest) | (10.3M) | (19.4M) | (73.0M) | 9.9M | 10.9M |
| EBT (Pre-Tax Income) | (16.4M) | (2.5M) | 28.4M | (79.3M) | (103.2M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (12.1M) | 401.0K | 39.8M | (64.2M) | (89.0M) |
| Earnings from Cont. Ops | (16.4M) | (2.5M) | 28.4M | (79.3M) | (103.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (20.6M) | (3.8M) | 32.4M | (66.3M) | (89.3M) |
| Per Share | |||||
| Basic EPS | ($16.36) | ($5.63) | $99.15 | ($274.92) | ($450.95) |
| Diluted EPS | ($16.36) | ($5.63) | $14.88 | ($274.92) | ($450.95) |
| Revenue Per Share | $0.02 | $0.11 | $9.29 | $10.17 | $1.90 |
| Shares | |||||
| Basic Shares Outstanding | 6.3M | 670466 | 322407 | 241052 | 197947 |
| Diluted Shares Outstanding | 6.3M | 670466 | 2.2M | 241052 | 197947 |
| Profitability Metrics | |||||
| EBITDA | (16.4M) | (2.3M) | 29.7M | (75.7M) | (99.5M) |
| D&A | 60.0K | 105.0K | 1.2M | 2.9M | 2.5M |
| EBIT | (16.4M) | (2.4M) | 28.5M | (78.7M) | (102.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026